Survival analysis indicated the increased expression of CD79A and CD96 was significantly associated with favorable relapse-free survival (RFS), overall survival (OS) in breast cancer (Figures 6C, D, , G, H). The gene discussed is CD79A; the disease is breast carcinoma.